Literature DB >> 18090284

Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients.

Edouard Tuaillon1, Yassine Al Tabaa, Vincent Baillat, Gaël Petitjean, Jacques Reynes, Jean Pierre Vendrell.   

Abstract

To investigate the maintenance of long-term memory B cells specific for hepatitis B surface antigen (HBsAg), purified blood B cells were polyclonally stimulated and cells secreting antibodies directed to HBsAg (HBs-SC) enumerated by ELISpot. HBs-SC were found in 18/20 HIV-1-infected patients with either natural or vaccinal immunity to hepatitis B virus, including six subjects with serum anti-hepatitis B surface antibody levels less than 10 mIU/ml. A lower number of HBs-SC was found in HBsAg-vaccinated patients compared with vaccinated controls.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090284     DOI: 10.1097/QAD.0b013e32827035b5

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  3 in total

1.  Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

Authors:  Zhenwu Luo; Lei Ma; Lumin Zhang; Lisa Martin; Zhuang Wan; Stephanie Warth; Andrew Kilby; Yong Gao; Pallavi Bhargava; Zhen Li; Hao Wu; Eric G Meissner; Zihai Li; J Michael Kilby; Guoyang Liao; Wei Jiang
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

2.  Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients.

Authors:  Jong Hun Kim; George Psevdos; Vanessa Groce; Victoria Sharp
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

3.  HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.

Authors:  Adam K Wheatley; Anne B Kristensen; William N Lay; Stephen J Kent
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.